P Brault

VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease

Vincent Ribrag, Fady Nasr, JH Bouhris et al. · Bone Marrow Transplantation · 1998 · 35 citations

Oncology, Pathology, Therapeutic Efficacy +5

Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.

Gérald Marit, C. Fabères, J L Pico et al. · Journal of Clinical Oncology · 1996 · 32 citations

Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice

JM Vantelon, Serge Koscielny, P Brault et al. · Bone Marrow Transplantation · 2000 · 28 citations

Hematological Malignancy, Prognostic Evaluation, Lymphoid Neoplasia +9

Prevention of Menstruation with Leuprorelin (GnRH Agonist) in Women Undergoing Myelosuppressive Chemotherapy or Radiochemotherapy for Hematological Malignancies: a Pilot Study

C. Lhommé, P Brault, J. H. Bourhis et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2001 · 24 citations

Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1.

A. Ibrahim, J L Pico, D Maraninchi et al. · PubMed · 1991 · 19 citations

Transplantation Surgery, Transplantation, Hepatology +12